This site uses cookies to bring you the best experience. Find out more
Skip to main content

News

Find Out The Latest

You can keep in touch with exciting developments for The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also keep up to date by following us on Twitter or LinkedIn    


Digital Catapult unveils five firms to explore potential of Open RAN technology on SONIC Labs testbed

Digital Catapult, with support from its partner Ofcom, has onboarded five companies to its SONIC Labs programme to trial the integration of Open RAN (Radio Access Network) products into working end-to-end systems Participating organisations will work collaboratively with each other, Digital Catapult and Ofcom to integrate and test their products in lab and indoor mobile network settings, accelerating their route to... Read more

Oxford Science Enterprises Raises £250 Million

New funding deepens capital pool available to drive the creation and growth of transformational businesses built on ground-breaking Oxford science Oxford, UK: July 18, 2022 – Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford, today announces it has raised a further £250 million ($300... Read more

MIROBIO RAISES $97M SERIES B TO DEVELOP CHECKPOINT AGONISTS FOR AUTOIMMUNE DISEASES

MIROBIO RAISES $97 MILLION SERIES B FINANCING TO DEVELOP CHECKPOINT AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASES Financing led by Medicxi with significant participation from new and existing shareholders Lead program MB272 targeting checkpoint receptor BTLA, entering Phase I clinical trials Funds will be used to advance pipeline of immune checkpoint agonists into clinical trials in autoimmune diseases OXFORD, United Kingdom, June 29... Read more

Drug discovery company OMass Therapeutics is 2022 winner of TOSP's Innovation Award

Work to discover drugs for rare and immunological diseases recognised as part of Oxfordshire Business Awards Oxford, UK, June 18 2022 – Its work in discovering medicines for rare and immunological diseases has earned OMass Therapeutics The Oxford Science Park Innovation Award 2022. Given as part of the Oxfordshire Business Awards, it recognises the company’s progress in generating a pipeline of small molecule therapeutics, discovered using... Read more

OxSonics strengthens management team with hire of Dr Marianna Lalla as Chief Medical Officer

OxSonics strengthens management team with appointment of Dr Marianna Lalla as Chief Medical Officer Underpins Company’s strategy to expand its pipeline of clinical combination studies Oxford, UK – 6th June 2022 – OxSonics Therapeutics, a world leader in the development of ultrasound-based drug delivery systems for the treatment of cancer, is pleased to announce that Dr Marianna Lalla has joined the Company as Chief Medical Officer (CMO).... Read more